Semaglutide × myaminolab peptides — lab test, June 2026
COA KVR-2026-10652F matches Kovera Labs's public record. So this test doesn't rest on our review alone — the lab confirms it too.
HT718AQTest results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 5 mg · Lab measured 5.56 mg
111% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 1.4 mg using the measured mass, against 1.3 mg on the label — 11% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | KVR-2026-10652F |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 8 Aug 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | Kovera Labs's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Semaglutide from myaminolab peptides, performed by Kovera Labs on June 24, 2026. Reported purity: 99.621%. Net content: 5.56 mg against 5 mg labeled (111% of label). Tested content exceeds the labeled amount by 11%. Batch V2606-S5-2401. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion